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2.Materials and methods 
2.1 C loning of Y4 receptor fragments starting with T M1 
7KHJHQHVFRGLQJIRU0LVWLFDQG/HSZHUHDPSOLILHGE\3&5LQWURGXFLQJD¶1GH,DQG
¶%DP+,restriction site; the two DNA fragments were then cloned in a pET21b vector 
(Novagen) between NdeI and BamHI sites. The gene coding for the human Y4 receptor 
ZDVDPSOLILHGE\3&5LQWURGXFLQJD¶%DP+,VLWHIROORZHGE\D&SURWHDVHFOHDYDJH
site (CTGGAAGTTCTGTTTCAGGGTCCGDQGD¶;KR,VLWH The PCR product was 
cloned between BamHI and XhoI into the pET21b vectors harboring mistic or lep. These 
two vectors were used as PCR templates for all the C-terminal truncations of the Y4 
receptor. The Y4 receptor fragments starting with TM1 were designed to have a Mistic-
3C protease site or a Lep-3C protease site fused to their N-terminus and green fluorescent 
protein (GFP) or the alkaline phosphatase (PhoA) to their C-terminus. The terminal 
residues of Mistic and Lep were E110 and Q86, respectively, and terminal residues of the 
Y4 receptor fragments are indicated in Suppl. Table 1. Gene fusions coding for Mistic or 
Lep and Y4 receptor fragments starting with TM1 were cloned using the FX cloning 
method [23] into derivatives of pBAD24 [24] containing open reading frames for a 3C 
protease cleavage site, EGFP and a decaHis-tag (pBXC3GH; [23]) or a linker sequence 
(VPDSYTQVASWTEPFPFC[25] WKH PDWXUH DONDOLQH SKRVSKDWDVH ǻ26-phoA) and a 
decaHis-tag (pBXCAPH; this work). For each construct, 5 µl of the FX cloning reaction 
was used to transform chemically competent E . coli '+Į$OOSODVPLGVZHUHVHTXHQFH
verified and used to transform chemically competent E . coli SF100 cells [26].  
  
2.2 C loning of Y4 receptor fragments ending with T M7 
The Y4 receptor fragments ending with TM7 were designed to have Mistic or Lep fused 
to their N-terminus and green fluorescent protein (GFP) or the alkaline phosphatase 
(PhoA) to their C-terminus. Derivatives of pBXC3GH and pBXCAPH containing open 
reading frames coding for Mistic or Lep in fusion with the full length Y4 receptor served 
DVWHPSODWHV7KHVHYHFWRUVZHUHDPSOLILHGXVLQJ¶SKRVSKRU\ODWHGSULPHUV7KHUHYHUVH
primer overlapped with the sequence coding for the 3C protease site located after Mistic 
or Lep. The forward primers overlapped with the starting positions in the Y4 receptor 
indicated in Suppl. Table 1. PCR products were digested with DpnI to remove the 
template vectors and subsequently gel purified. 50 ng of DNA in a volume of 8 µl was 
supplemented with 1 µl of 10X T4 ligase buffer and 1 µl of T4 DNA ligase (1U) and 
subsequently incubated for 1 hour at RT. After heat-inactivating the T4 ligase for 20 min 
at 65qC, 5 µl of the ligation reaction was used to transform DH5D cells. All constructs 
were sequence-verified and transformed to E . coli SF100 cells.  
 
2.3 C loning of Emr E and its mutants 
The gene encoding for the wild-type EmrE was amplified from genomic DNA of E . coli 
MC1061 by PCR using primers compatible with the FX cloning method. The EmrE 
mutant R29G/R82S [27] was obtained by overlapping PCRs and cloned in pBXC3GH 
and pBXCAPH using FX cloning. 
 
 
 
2.4 C loning of fragments pairs for co-expression 
Individual genes coding for the complementation pairs TM1-3/TM4-7 and TM1-5/TM6-7 
were manipulated in the pBXC3GH vector to: 1) contain a second 3C protease site 
adjacent to the first site between Mistic and the fragment; 2) remove the 3C protease site 
between the fragment and GFP; and 3) remove the His-tag for TM4-7 and TM6-7. 
6XEVHTXHQWO\ WKH FRQVWUXFWV ZHUH 3&5 DPSOLILHG LQWURGXFLQJ ¶ 1FR, DQG D ¶ 1RW,
restriction sites (Mistic-TM1-3-GFP-His and Mistic-TM1-5-GFP-+LVRU¶1GH, DQGD
¶3DF,UHVWULFWLRQVLWHV0LVWLF-TM4-7-GFP and Mistic-TM6-7-GFP). The PCR products 
coding for the complementation pairs were then cloned in one pCDFDuet-1 vector 
(Novagen) to allow co-expression. In addition, genes coding for Mistic-TM4-7-GFP and 
Mistic-TM6-7-GFP were also cloned in the pCDFDuet-1 vectors without the gene coding 
for their complementation partner. These constructs served as negative controls. All 
vectors were sequence-verified. 
 
2.4 G FP fluorescence determination in whole cells 
Overnight cultures were started from single colonies on LB agar plates and grown in 0.7 
ml LB supplemented with ampicillin (LB-amp) at 37°C with vigorous shaking in 96 
deep-well plates covered with a gas-permeable seal. The overnight cultures were diluted 
1:100 in 0.7 ml of LB-amp in a 96 deep-well plate. Cells were grown for 1 hour at 37°C 
after which the temperature of the incubator was set to 25°C and cultivation continued for 
90 minutes after which the cells were induced with 0.2% (w/v) arabinose. The 
approximate optical density of the culture at this point was OD600= 0.5. Cultivation was 
continued for four hours and cells were harvested by centrifugation (3000 g, 10 min), 
washed once with 500 µl of 50 mM KPi, pH 7.5, 150 mM NaCl and resuspended in 300 
µl of the same buffer. GFP fluorescence of whole cells was determined on 150 µl aliquots 
of these cell suspensions in a black 96 well plate (Nunc, Denmark) using an Infinite 
M1000 plate reader (Tecan, Switzerland) with excitation at 485 nm and emission at 535 
nm. OD600 values were determined using 50 µl of the cell suspension in a transparent 96 
well plate. All the fluorescence values were normalized by OD600 and mean values were 
obtained by performing the experiment at least twice using biological triplicates. 
2.5 PhoA activity determination in whole cells 
Overnight cultures and cultivation for expression were performed as described above, 
except that cells were induced with 0.2% (w/v) arabinose already after 1 hr cultivation at 
37°C. At this stage the optical density of the culture was approximately OD600 = 0.2. 
Growth was subsequently continued for one hour at 37°C. Ten minutes before harvesting, 
1 mM iodoacetamide was added to prevent oxidation of alkaline phosphatase located in 
the cytoplasm [28]. All buffers used afterwards contained 1 mM iodoacetamide. Cells 
were washed at 4°C with 300 µl of 1 M Tris-HCl, pH 8.0, and the OD600 was measured 
using 50 µl of the cell suspension in a transparent 96 well plate. The suspension was 
subsequently pelleted and cells were resuspended in 300 µl of 1 M Tris-HCl, pH 8.0, 
containing 1.3 mM p-nitrophenyl-phosphate and incubated in the dark at 37°C until a 
yellow color developed. Next, cells were pelleted (3000 g, 10 min, 4°C) and the A420 of 
150 µl supernatant was determined using an Infinite M1000 plate reader. Mean activity 
values were obtained from two independent experiments performed using biological 
triplicates. The absorbance at 420 nm was normalized for the optical density at 600 nm.  
2.6 In gel fluorescence and solubilisation assay 
Protein samples were prepared as described elsewhere [29], except that whole-cell 
samples corresponding to ~ 2 mg of protein were used. Protein samples were analyzed by 
15% SDS-PAGE, and in gel GFP fluorescence was visualized with an LAS-3000 
imaging system (Fujifilm, Switzerland) and AIDA software (Raytest, Germany). The 
solubilization assay was done as described in [29] with the exception that 1 mM DTT 
was added to all the buffers. The detergents dodecylphosphocholine (DPC), 1-myristoyl-
2-hydroxy-sn-glycero-3-phosphatidyl-glycerol (LMPG), n-dodecyl-ȕ-d-maltoside 
(DDM), octaethylene glycol monododecyl ether (C12E8; all purchased from Anatrace, 
Canada) were added to a final concentration of 1% (w/v). 
2.7 Preparation of membrane vesicles 
Overnight cultures of E . coli SF100 containing pBXC3GH derivatives for selected 
Mistic-Y4 fusions were grown at 37°C in Terrific-broth supplemented with 0.1 mg/ml 
ampicillin (TB-amp). A 1% (v/v) inoculum was used to start growth in four 2.5 liter 
baffled flasks each containing 1 liter TB-amp. Cells were grown for 1 hour shaking at 
37°C after which the temperature was lowered to 25° C over the course of 90 minutes. 
After induction with 0.2% (w/v) arabinose, cultivation continued for 16 hours. Cells were 
harvested by centrifugation at 6000 g for 15 min at 4°C. The cell pellet was resuspended 
in ice-cold 50 mM KPi, pH 7.5, 150 mM NaCl to an OD600 between 150 and 200. The 
suspension was supplemented with lysozyme (1 mg/ml), DNase (20 Pg/ml) and MgCl (1 
mM), homogenized and stirred for 1 hour at 4°C. Cells were disrupted by three passes 
through a cooled pressure cell (Emulsiflex) at 15 kPsi before protease inhibitor tablets 
(Roche) were added. Unbroken cells were removed by centrifugation at 15000 g for 15 
minutes at 4°C. Subsequently, the membrane vesicles in the supernatant were pelleted by 
centrifugation at 120000 g at 4°C for 1 hour. Membrane vesicles were homogenized in 50 
mM KPi, pH 7.5, 150 mM NaCl, and 10% glycerol using a Potter tube to a final 
concentration of 1 gr (wet weight) of membrane vesicles per 2 ml buffer and immediately 
frozen in liquid nitrogen and stored at -80°C. 
 
2.8 Purification of the Mistic-Y4 fragment-G FP fusions 
Membrane vesicles containing Y4 receptor fragments overexpressed as fusions to Mistic 
(N-terminus) and GFP-His (C-terminus) were solubilized at a concentration of 1 gr 
vesicles (wet weight) to 10 ml solubilization buffer (50 mM KPi, pH 7.5, 300 mM NaCl, 
5% glycerol, 1 mM DTT, 1% (w/v) DPC and 15 mM imidazole), while stirring for 1 hour 
at 4°C. All subsequent steps were performed at 4°C. Insoluble material was removed by 
centrifugation at 120000 g for 30 minutes. The supernatants were then incubated for 1 
hour with Ni-NTA resin (HIS-Select, Sigma, Switzerland; ~0.6 ml resin per gr vesicles) 
pre-equilibrated in solubilization buffer. The resin was subsequently washed with ten 
column volumes (CV) 50 mM KPi, pH 7.5, 300 mM NaCl, 5% glycerol, 5 mM DPC and 
30 mM imidazole. Proteins were eluted in 0.5 CV fractions with 50 mM KPi, pH 7.5, 300 
mM NaCl, 5% glycerol, 5 mM DPC and 300 mM imidazole and subsequently injected 
into a Superdex 200 (10/300 GL) SEC column (GE), pre-equilibrated with wash buffer 
devoid of imidazole. Peak fractions were subsequently re-injected. 
 
 
 
2.9 Co-expression and co-purification of fragments pairs 
Co-expression of the complementing fragment pairs TM1-3/TM4-7 and TM1-5/TM6-7 
was done in E .coli BL21 (DE3) using the pCDFDuet-1 derivatives described in Section 
2.4. Overnight cultures were started from single colonies and grown in 10 ml-LB broth 
supplemented with 0.1% streptomycin at 37 °C, shaking. The overnight cultures were 
diluted 1:100 in 600 ml of TB (2 liters/each fragment pair) and cells were grown for 2 
hours at 37°C, shaking. Subsequently the temperature was lowered to 25°C over the 
course of 1 hour, cultures were induced with 0.2 mM IPTG and cultivation was continued 
for 16 hrs. Cells were harvested and membrane vesicles were prepared as described in 
Section 2.7. Purification of the fragments pairs was performed as described in Section 
2.8, except that all buffers contained 10% glycerol and 150 mM NaCl. In addition, the 
Ni-NTA resin (~0.5 ml per gr membrane vesicles) was washed more extensively, using 
four times ten CV of washing buffer (50 mM KPi, pH 7.5, 150 mM NaCl, 10 % glycerol, 
5 mM DPC), supplemented with 30, 5, 30 and 5 mM imidazole, respectively. Proteins 
were finally eluted in 0.5 CV fractions using an elution buffer containing 300 mM 
imidazole. Expression and purification of the negative control samples was performed 
identically.  
  
3. Results. 
3.1 Design of the fusion proteins. 
Structural characterization of proteins by NMR requires high and robust protein 
expression levels, and should ideally also include the possibility for perdeuteration. As a 
result, expression of labeled protein is almost exclusively done in E . coli where the 
protein is produced to high levels in inclusion bodies. Subsequent refolding is required to 
obtain well-folded material. Unfortunately, this robust strategy is often not successful for 
alpha-helical membrane proteins due to the difficulties in refolding them in a functional 
form a>NF! >Mb. To some extend the formation of inclusion bodies can be avoided by 
decreasing the expression rate, e.g., by lowering the cultivation temperature or using a 
weaker promoter, thus allowing expression in the membrane in a folded state [29].  
To determine which fragments of the Y4 receptor were amenable to overexpression in a 
folded state, we created a set of six truncation mutants from the N-terminus and a set of 
six truncation mutants from the C-terminus, differing in length by multiples of single 
alpha-helices (Fig. 1). To allow for correct processing by the membrane protein insertion 
machinery, for each fragments starting with a residue that was expected to be on the 
outside of the cell based on a structural model, the N-terminus was fused to Lep or 
Mistic. Lep adopts a well-characterized Nout-Cout topology, while for Mistic, a protein 
from B. subtilis that associates tightly with the membrane, the topology is less well 
defined (vide infra). However, Mistic has been suggested to facilitate and enhance 
expression of both membrane proteins with an Nout or Nin topology [22] aN@F!N>b. For this 
reason, we also fused Mistic to fragments with a proposed cytoplasmic N-terminus. We 
observed that w+/0$./!`&(!$%!Y+'/+9! 8.'+$)'F! 8%-,:&)/'! 3$9-3+I&! +)! /0&! +)93.'+$)!6$*+&'!
H0&)!&O(%&''&*!+)!"#!$%&'!aM@bP!!
Lacking a functional assay to determine the specific activity of the fragments, we used 
the membrane topology as an initial indicator for a correct folding state. As reporters for 
a cytoplasmic or periplasmic location of the C-terminus, the well-established topology 
indicators GFP and PhoA were used [18, 31]. These indicator proteins were fused to the 
C-terminus of each fragment. Only GFP located in the cytoplasm will become fluorescent 
as iWUHPDLQV³GDUN´ZKHQH[SUHVVHGLQWKHSHULSODVP,QFRQWUDVWRQO\3KR$H[SUHVVHG
in the periplasm will mature and become functional while cytoplasmic PhoA remains 
inactive if cultivation is limited to several hours [28]. In addition to this, GFP is used as a 
reporter for protein folding as well [18, 29, 32]. Since the GFP signal reports both folding 
and topology, it potentially complicates the analysis. Nevertheless a good agreement has 
been found between membrane topology models determined by PhoA/GFP reporter 
fusions and the corresponding high-resolution 3D structures [33-38]. Possibly, the PhoA 
fusion protein reports on folding as well to a similar extend as GFP does.  
Except for PhoA, all N- and C-terminal fusion proteins were separated from the Y4 
receptor fragments by a 3C protease site to allow future analysis of the fragment only. All 
combinations of Y4 fragments and different N- and C-terminal fusion partners, 
amounting to 46 different constructs, were expressed in the same E . coli strain, SF100. 
This strain is compatible with both GFP and PhoA assays [26].  
 
 
 
3.2 Topology of the Y4 receptor fragments 
For each Y4-fragment, we determined the PhoA activity and the GFP fluorescence of the 
corresponding fusion proteins using biological triplicates (Fig. 2A). Constructs displaying 
high GFP fluorescence and low PhoA activity are indicative of membrane proteins with a 
pronounced cytoplasmic localization, whereas high PhoA activity and low GFP 
fluorescence are indicative of a periplasmic localization of the C-terminus. Mixed or dual 
topology is characterized by proteins displaying both significant GFP and PhoA signals. 
To validate our setup, we made use of three proteins for which the location of the C-
terminus had been determined previously. LacS is a transport protein with twelve TM 
segments and a cytoplasmic C-terminus [39]. Lep contains the first two TM segments 
preceding the periplasmic domain of the membrane-bound protease Leader Peptidase 
[19]. Next to these membrane proteins with one clear topology, we used EmrE as an 
example of a protein with a dual topology. More specifically, we used EmrE(R29S/R82S) 
as this mutant shows a more similar population of both topologies compared to wild-type 
EmrE. The dual topology of EmrE has been shown to be essential for its activity [27]. We 
observed high GFP fluorescence for LacS and high PhoA activity for Lep as expected for 
membrane proteins with a Cin or Cout topology, respectively. In contrast, 
EmrE(R29S/R82S) displayed intermediate values (Fig. 2A). Taken together, these results 
confirmed the predictive value of the GFP/PhoA reporter assay. We subsequently 
analyzed Mistic as well to determine the preferred location of its C-terminus. Though 
Mistic has been shown to facilitate the expression of proteins with an Nout topology [22], 
our data indicate that Mistic not fused to any Y4 fragment has its C-terminus located in 
the cytoplasm. To normalize data, we arbitrarily set the high GFP fluorescence of Mistic-
GFP and the high PhoA activity of the Lep-PhoA fusion protein to 1.  
Fusions between Mistic and the Y4 receptor fragments generally displayed higher GFP 
and PhoA signals than the corresponding Lep-fusions, which is indicative of higher 
expression levels (Fig. 2A). For both Mistic and Lep fusions, it was in general difficult to 
unambiguously assign a defined topology, as often the difference in activities of both 
reporter proteins was small. To correct for differences in the expression levels of the 
different fusions, we plotted the ratio of the PhoA to GFP signals for each fragment (Fig. 
2B). A PhoA/GFP ratio of 1, or a Log(ratio) of 0, in principle corresponds to a 1:1 mixed 
topology (50% Cout and 50% Cin). However, we like to emphasize that the PhoA/GFP 
assay is not sufficiently quantitative to determine topology distributions in such an exact 
fashion as the scaling of both axis is arbitrary. Fusions between Mistic and Y4 fragments 
starting with TM1 showed an alternating PhoA/GFP ratio with every extra TM segment 
(Fig. 2B). Constructs with an odd number of TM segments display a low PhoA/GFP 
ratio, whereas constructs with an even number of TM segments show a higher PhoA/GFP 
ratio, in agreement with the expected topology for GPCRs. In addition, for nearly every 
extra TM segment added, the topology becomes more skewed towards one particular 
state, indicating that the fraction of well-oriented fragments and thus the overall quality 
of folding is improved in the longer constructs. 
Interestingly, the opposite trend is observed for the fusions between Mistic and N- 
terminally truncated Y4 fragments. Here, shortening the constructs by progressively 
removing TM segments from the N-terminus leads to a more clearly defined Cin-
topology. These observations suggest that the C-terminus rather than the N-terminus of 
the protein is important for establishing the correct topology in the entire receptor. 
Overall, similar trends were observed when using fusions between Lep and Y4 
fragments, though the differences in the PhoA/GFP ratios were less pronounced 
compared to the Mistic-based fusions.  
The average log PhoA/GFP ratio for the fusions of Mistic and Y4 fragments starting with 
TM1 was lower (-0.44) than the average ratio of the corresponding Lep fusions (+0.22). 
As all constructs were measured under identical conditions, this suggests that either the 
Lep fusions have a higher tendency for a periplasmic C-terminus, or the Mistic fusions 
incline more towards a C-terminus located in the cytoplasm.  
To conclude, our results indicate that most probably the Y4 fragments studied here exist 
as mixtures of proteins with correct and incorrect locations of the C-terminus. However, 
the distribution of the topologies is not random. For the Y4 fragments starting with TM1 
a clear trend in the PhoA/GFP ratio can be seen, suggesting an increased preference of 
the fragments towards the correct topology. Likewise, most Y4 fragments ending with 
TM7 display comparably low PhoA/GFP ratios in line with a correct location of the C-
terminus in the cytoplasm. These data are indicative of a correct topology for a 
predominant fraction of the material. 
 
3.3 Purification of individual fragments in fusion with Mistic 
As the Mistic-fusions showed in general: 1) more pronounced differences in the 
PhoA/GFP ratio suggesting a more defined topology; and 2) higher absolute PhoA- and 
GFP-signals suggesting higher expression levels, we selected only Mistic-Y4 fragments 
for further analysis. Furthermore, we observed that expression of Mistic-Y4 fragments 
affected cell growth less than the corresponding Lep-fusions resulting in approximately 
five-fold higher final cell densities (data not shown).  
We selected the Mistic-Y4 fragment complementation pairs TM1-3 plus TM4-7, and 
TM1-5 plus TM6-7 for further analysis based on their pronounced PhoA/GFP ratios, and 
comparably high expression levels. The fragments were expressed identically as for the 
topology assay to assure that the quality of the material was not affected. All fragments 
contained a C-terminal His-tagged GFP to facilitate detection and purification. As 
stability of purified membrane proteins depends strongly on the detergent used for 
solubilization, we screened four different detergents for their efficiency to solubilize 
these fragments. The detergents DDM and C12E8 are commonly used for crystallization 
of membrane proteins [40]. The detergents DPC and LMPC were selected since they 
have proven to be particularly useful for NMR spectroscopy [41-43]. We compared 
whole cell lysates solubilized with the respective detergents with the supernatant of the 
same lysate after ultracentrifugation (Fig. 3C). Provided solubilization is successful, the 
intensities of the GFP signal before and after centrifugation are expected to be equal. In 
contrast, aggregation or incomplete solubilization will reduce the GFP signal in the 
supernatant after centrifugation, as the insoluble material will pellet. Using DDM and 
C12E8, all four selected fragments and the full-length receptor were completely removed 
from the solubilization mixture, indicating poor stability and/or incomplete solubilization 
using these detergents. LMPC only solubilized a fraction of the Y4 receptor fragments. 
Detergent-solubilization tests indicated that only DPC was able to quantitatively recover 
the fragments (Fig. 3C). DPC is generally known for its high efficiency in solubilizing 
membrane proteins [12, 40, 44], but in addition has been shown to solubilize even 
misfolded membrane proteins [29]. In contrast, DDM, a mild detergent that tends to 
selectively solubilize well-folded membrane proteins [29], did not solubilize the 
fragments. Though this preference for DPC could be related to the folding state, there are 
many examples of membrane proteins with distinct preferences for certain detergents, 
and this property could be a peculiarity of these fragments as well.  
Using DPC we were able to purify the four fragments and the full-length receptor to 
~90% purity by IMAC (Fig. 3A). We obtained approximately 3-5 mg of each Y4 receptor 
fragment per liter of culture. For all the fragments two major bands were observed with a 
difference in molecular weight of 10-15 kDa. Only the lower band was fluorescent (Fig. 
3B). This dual migration behavior has been observed before and has been correlated to a 
well-folded fraction, represented by the fluorescent band with a higher electrophoretic 
mobility, and a fraction of aggregated material, represented by the non-fluorescent band 
with lower electrophoretic mobility [29]. However, here the signal of the GFP reports not 
only on the folding quality of the fragments, but on their membrane topology as well. 
Like aggregated protein, protein inserted in the opposite topology is likely to be 
misfolded and not expected to solubilize efficiently nor show similar migration properties 
as well-folded protein. To verify whether a fraction of the protein is indeed not in a well-
folded state, or whether the non-fluorescent GFP-fusions represented a fraction folded but 
misoriented fusion proteins, we analyzed the Y4 receptor fragments by size exclusion 
chromatography (SEC). Analysis of the samples by SEC revealed identical migration for 
both fluorescent and non-fluorescent GFP-fusion protein suggesting that both species do 
have a similar stable folding state (Fig 3B). Only a fraction of the material was 
aggregated and eluting in the void fraction (Suppl. Fig. 1). The remaining protein 
migrated in a broad oligo-disperse peak of which the peak fraction proved quite stable. 
Upon reinjection of this peak fraction, one relatively broad single peak was obtained (Fig. 
3D).  
Further analysis of the Y4-fragments by NMR would require removal of the fusion 
partners as these would complicate the analysis of the NMR spectra and introduce 
undesired heterogeneity. For this purpose, both Mistic and GFP were connected to the Y4 
fragments by a 3C protease cleavage site. Digestion of the purified fusion proteins with 
the 3C protease readily cleaved of the GFP moiety, but was very inefficient in cleaving 
the protease site between Mistic and the Y4-fragments (data not shown). Addition of a 
second 3C protease site between Mistic and the Y4 fragments resulted in a virtually 
complete digest (Suppl. Fig. 2). 
 
3.4 Co-purification of complementing Y4-fragment pairs. 
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4. Discussion. 
Structural characterization of membrane proteins by NMR is still in its infancies despite 
significant recent progress (reviewed in [46, 47]). In order to enable studies of larger 
membrane proteins, we are presently exploring alternative approaches using large 
fragments of the human Y4 GPCR as a model system for two purposes: first, we intend to 
obtain structural data on these fragments to learn about the assembly of the TM bundle 
and to obtain chemical shift assignments that may be useful when studying the entire 
receptor; second, we plan to split the entire receptor into two large fragments that will be 
produced separately to allow individual isotope-labeling schemes. Upon subsequent 
mixing the fragments should reconstitute into a fully functional receptor, for which 
resonance assignments are facilitated because only part of the protein is labeled. 
Complementation approaches have been pursued before for rhodopsin [48], the E-
adrenergic [49] and the Ste2p receptors [50]. These studies showed that functional 
receptors could be reconstituted upon co-expression of fragments in eukaryotic cells. To 
the best of our knowledge, the production of interacting GPCR fragments in prokaryotic 
cells has not been reported so far. 
Herein we constructed an extensive set of expression vectors for Y4 receptor fragments 
truncated from the N- or C-terminus thereby covering each possible combination of 
complementary fragments (Fig.1). To ensure an appropriate location of the N-terminus 
and to enhance protein expression levels, we fused the N-termini of the fragments to 
either Lep or Mistic. In addition, we determined the quality of the fragments expressed. 
Though protein quality is preferably assessed by determining specific activities, this 
approach is here not feasible as the fragments do not posses any function. As an 
alternative, here we rapidly probed the folding quality of the fragments on a basic level 
by analyzing their topology within the context of a biological membrane.  
For both Lep- and Mistic-fusions starting with TM1, we observed an increase in the 
PhoA/GFP ratio with fragments containing an even number of TM segments, and a 
decrease in the ratio for fragments with an odd number, in agreement with their predicted 
periplasmic and cytoplasmic orientations (Fig. 2B). Despite the appropriate trends of the 
PhoA/GFP ratios, their absolute values mostly span a range in between those of proteins 
with a clear Cin or Cout topology such as LacS or Lep. This suggests that for most 
fragments both properly oriented and misoriented species co-exist. Nevertheless, a clear 
preference for the correct topology could be observed, providing an early indication that a 
significant fraction of the material was correctly folded in the membrane.  
Next to this, we observed that the Y4 fragments adopted a less mixed topology if the C-
terminal TM segments represented a larger fraction of the Y4 fragment (Fig. 2B). This 
suggests that the C-terminal part of the Y4 GPCR has a larger influence on adopting the 
predicted topology than the N-terminus. Hessa et al. established a biological scale for 
determining the propensity of a TM segment to insert in a biological membrane based on 
its amino acid sequence [51]. This scale considers the TM segments as isolated helices 
and thereby explicitly neglects the contributions from interhelical interactions. In 
addition, the preferred orientation of the TM segments in the membrane correlates 
strongly to the amount of positive charges in the connecting loops (positive-inside rule, 
[52]). The distribution of charges in the loops of the Y4 GPCR is conform to the positive-
inside rule (Fig. 5A). Importantly, the calculated propensities for the TM segments of the 
Y4 GPCR using the biological partitioning scale are in agreement with our observations 
(Fig. 5B). The N-terminal TM segments are predicted to not fully integrate into the 
membrane, indicating that they require interhelical interactions for proper membrane 
insertion. Their weak propensity to insert may explain the multiple topologies of TM1 up 
to TM1-3 as derived from the GFP/PhoA ratios. Interestingly, our recent studies of the 
Y4 TM1-TM2 fragment in a model membrane system (LPPG micelles) using NMR 
techniques also revealed that secondary structure in the helices is not stably formed, and 
that both helices do not fully integrate into the micelles [53]. In contrast, TM segments in 
the C-terminal half of the receptor have a larger propensity to insert into the membrane 
and thereby may help in stabilizing the N-terminal TM segments in a hydrophobic 
environment. As a result, the mixture of topologies is skewed towards their native 
orientation resulting in PhoA/GFP ratios reflecting more unique topologies.  
Though the use of Mistic- and Lep-fusions to the N-terminus of fragments with a 
predicted Nout topology provided qualitatively similar results, a few important differences 
were noted. First, only the Mistic-fusions expressed at levels compatible with economical 
production of isotope-labeled protein (3-5 mg protein after IMAC/liter culture), in 
agreement with previous observations [22, 54]. Second, the average PhoA/GFP ratios for 
the Mistic- and Lep-fusions differed greatly: Lep-fusions displayed higher average 
PhoA/GFP ratio than Mistic-fusions (Figure 2A). As the PhoA and GFP signals cannot be 
directly compared, it is not possible to specifically attribute this difference to a higher 
average PhoA activity for Lep-fusions or a higher average GFP-activity for Mistic-
fusions. It is however in line with the preferred topologies determined for the fusion 
proteins alone (Cout for Lep, Cin for Mistic).  
Based on the high expression levels and on the PhoA/GFP ratios that suggested a 
significant fraction of protein with a proper folding state, we selected the Mistic- and 
GFP fusions of the complementation pairs TM1-3 plus TM4-7, and TM1-5 plus TM6-7 
for further analysis. These fragments were expressed well in E .coli and could be 
solubilized efficiently in DPC detergent. The purified proteins proved to be stable in 
detergent. Moreover, the fusion proteins could be removed using the 3C protease, 
although in case of Mistic two 3C sites were required for proper processing. 
Though the purified Y4 GPCR fragments showed good stability upon reinjection of the 
main SEC peak, the mixed topologies, the requirement for DPC, the dual migration of the 
GFP-fusions and the broad peak during the initial analysis by SEC raised concerns about 
the folding state of the protein produced. To determine whether the selected 
complementing Y4-fragments are in principle able to stably interact, the 
complementation pairs TM1-3 plus TM4-7 and TM1-5 plus TM6-7 were co-expressed. 
Upon purification, we observed specific co-elution of the untagged TM4-7 and TM6-7 
with their respective His-tagged complementation partners TM1-3 and TM1-5. This 
suggests that at least a significant fraction of these Y4 GPCR fragments is in a state that 
allows a strong physical interaction with its complementation partner. Our topological 
study suggests that the fragment starting with the N terminus is better folded the longer it 
is, and hence the TM1-5 fragment is expected to be preferable over the TM1-3 fragment. 
Our co-purification data indicate that this is indeed the case. We conclude with the 
statement that our study suggests that producing complementary fragments presents a 
promising route to obtain a reconstituted receptor that can be a useful system for 
simplifying its spectroscopic characterization by NMR. 
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F igure Captions 
F igure 1: Schematic representation of the truncated versions of the human Y4 receptor 
used in this study. Constructs are divided in C-terminal and N-terminal truncations. 
Mistic and Lep (blue and gray triangles) were used as fusion proteins to obtain an Nout 
topology for the Y4 receptor fragments where needed and to enhance expression levels of 
fragments with an Nin topology (Mistic only, blue triangles). GFP and PhoA were used as 
C-terminal reporter proteins for cellular localizations (indicated by a circle).   
 
F igure 2: Membrane topology of Mistic- and Lep-fusion of Y4 GPCR fragments as 
determined with the PhoA/GFP reporter assay. `-9GF!`&(!-)*!R:%R"! %&(%&'&)/!9$)/%$3!
:&:6%-)&! (%$/&+)'! H+/0! -! 9;/$(3-':+9F! (&%+(3-':+9! $%! :+O&*! 3$9-/+$)! $8! /0&+%! #B
/&%:+).'F!%&'(&9/+4&3;P!R:%R"!*&)$/&'!/0&!SN?TfSCNG!*$.63&B:./-)/!$8!R:%RP!]e!TW\!
83.$%&'9&)9&!d63-9^!6-%'e!-)*!\0$]!-9/+4+/+&'!dH0+/&!6-%'e!6-'&*!$)!6+$3$,+9-3!/%+(3+9-/&'!
H&%&!)$%:-3+I&*!-)*!(3$//&*! +)!(-+%'! 8$%!&-90! +)*+4+*.-3!9$)'/%.9/P!Ve! 3$,! d\0$]fTW\e!
4-3.&'!8$%!&-90!+)*+4+*.-3!9$)'/%.9/P!
 
F igure 3: Purification of selected fragments of the Y4 GPCR. A) SDS-PAGE analysis of 
single fragments purified in 5 mM DPC using IMAC and SEC. White and black arrows 
indicate the non-fluorescent and fluorescent species of the purified constructs, 
respectively. B) In gel GFP fluorescence of the gel depicted in panel A prior to 
Coomassie staining. Black arrows indicate the fluorescent target band. C) Differential 
sedimentation of the Mistic- and GFP-fusions analyzed by in gel fluorescence. Whole 
cell lysates were disrupted by bead beating and solubilized with 1% DDM, 1% C12E8, 1% 
DPC, or 1% LMPC. T and S represent samples taken before (Total protein) and after 
(Solubilized protein) ultracentrifugation, respectively. D) SEC of reinjected peak 
fractions from a previous run (Suppl. Fig. 1). 
 
 
F igure 4: Co-purification of complementing Y4 GPCR fragments pairs. A) Samples 
taken at different stages of the purification from membranes containing Mistic-TM1-3-
GFP-His tag and Mistic-TM4-7-GFP (labelled Test) or Mistic-TM4-7-GFP alone 
(labelled Negative control). B) Samples taken at different stages of the purification from 
membranes containing Mistic-TM1-5-GFP-His tag and Mistic-TM6-7-GFP (labelled 
Test) or Mistic-TM6-7-GFP alone (labelled Negative control). Upper and lower panels 
indicate the same gel after imaging by in gel GFP fluorescence and Coomassie staining, 
respectively. Labels refer to marker (M), solubilized membranes (SOL), flow though 
(FT), first wash (W1), second wash (W2), third wash (W3), fourth wash (W4) and elution 
(ELU). The position of the fluorescent fraction of the protein is indicated by white and 
black arrows. 
 
Figure 5: Charge distribution in loops and calculated insertion propensities for individual 
TM segments of the Y4 GPCR. (A) Net charge of all Y4 GPCR loops.  (B) Free energies 
for transferring entire TM segments into the membrane using a biological scale[56]. 
Amino acid sequences of the TM helices are indicated in Suppl. Table 2.   
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Suppl. Fig.1: Normalized size exclusion profiles of the constructs TM1-3, TM1-5, TM1-7, 
TM4-7 and TM6-7. All constructs were N-terminally fused to Mistic and C-terminally to the 
GFP, purified by IMAC as described in Materials and Methods and subsequently injected in a 
Superdex 200 (10/300 GL) (GE). Fractions corresponding to the main peak were re-injected 
(dotted lines). 
 
 
 
 
 
  
 
 
Suppl. Fig. 2: Enzymatic cleavage of Mistic from the co-purified fragments pairs. Fragments 
pairs TM13/TM47 and TM15/TM67 were co-expressed and co-purified as described in 
Materials and Methods. Fractions corresponding to the main elution peaks were used as test 
for the efficiency of the Mistic removal upon addition of 3C protease. The cleavage was 
performed at 20 °C for 12 hours in 150mM NaCl, 50mM KPi pH 7.5, 10% glycerol, 1mM 
DPC. The final concentration of 3C protease was 70 µM. 
 
 
 
 
 
 
 
  
 
 
Suppl. Table 1: Molecular weights and positions at which the N- and C-terminal fragments 
of the Y4 GPCR have been truncated. 
 
 
 
 
 
Suppl. Table 2:  Amino acid sequences of the single alpha helices from the Y4 GPCR used 
as input for calculating the !Gapp for membrane insertion using the !G prediction server v1.0 
(http://dgpred.cbr.su.se/). 
